NYC company launches non-invasive cheek swab test to assess biological age
Tally Health, a New York City biotechnology company, has developed a non-invasive cheek swab test called CheekAge to predict biological age. This method differs from traditional tests that rely on blood DNA. Recent research published in *Frontiers in Aging* shows CheekAge is significantly linked to mortality risk, even when tested against blood samples from 1,500 UK seniors. The test uses cheek cells, making it easier and less invasive. CheekAge, launched earlier this year, is part of Tally Health's TallyAge Test kit. It has been found to correlate with lifestyle and health factors, such as sleep and COVID-19 history.